Versant Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11
| Closed | -$517 | – | 2546 |
|
|
2024
Q4 | $517 | Buy |
+11
| New | +$517 | ﹤0.01% | 2269 |
|
|
2021
Q2 | – | Sell |
-419
| Closed | -$10K | – | 1471 |
|
|
2021
Q1 | $10K | Sell |
419
-205
| -33% | -$4.89K | ﹤0.01% | 783 |
|
|
2020
Q4 | $12K | Sell |
624
-39
| -6% | -$750 | ﹤0.01% | 671 |
|
|
2020
Q3 | $14K | Hold |
663
| – | – | 0.01% | 535 |
|
|
2020
Q2 | $15K | Buy |
663
+314
| +90% | +$7.1K | 0.01% | 498 |
|
|
2020
Q1 | $4K | Buy |
349
+12
| +4% | +$138 | ﹤0.01% | 823 |
|
|
2019
Q4 | $3K | Hold |
337
| – | – | ﹤0.01% | 1055 |
|
|
2019
Q3 | $3K | Hold |
337
| – | – | ﹤0.01% | 1078 |
|
|
2019
Q2 | $3K | Buy |
337
+256
| +316% | +$2.28K | ﹤0.01% | 1084 |
|
|
2019
Q1 | $0 | Hold |
81
| – | – | ﹤0.01% | 1588 |
|
|
2018
Q4 | $0 | Hold |
81
| – | – | ﹤0.01% | 1499 |
|
|
2018
Q3 | $0 | Buy |
+81
| New | – | ﹤0.01% | 1538 |
|
|
2018
Q2 | – | Sell |
-21
| Closed | – | – | 1529 |
|
|
2018
Q1 | $0 | Buy |
+21
| New | – | ﹤0.01% | 1512 |
|